How Comparative RWE Can Help You with HTA and Payors When No RCT Evidence is Available

Watch this recorded webinar to learn from Prof. Dr. Thomas Wilke, faculty member of Generating RWE for Optimising Market/Patient Access. On 17 October 2024, he shared his insights on :

  • What is better and what is more accepted: comparative RWE versus indirect comparisons based on trials.

  • Synthetic control groups and post-approval comparative RWE studies: How do they work?

  • Existing guidance and guidelines for comparative RWE studies 

 

 

 

Learn more from this expert at the following short duration course(s):